Taxus Liberte: Additional data

Additional data from the ATLAS Long Lesion study showed that the Taxus Liberte Long Stent significantly reduced the rate of target-vessel myocardial infarction (MI) (2.6% vs. 12.9%, p=0.02) and target-vessel non-Q-wave MI (2.6% vs. 11.3%, p=0.03) at 4 years vs. Taxus Express. Rates of target lesion revascularization (TLR), major adverse cardiac events, and stent thrombosis were similar between treatment arms. Data were presented at the Transcatheter Cardiovascular Therapeutics meeting in Washington. ...